Immuno-oncology in 2018: Overcoming Challenges to Revolutionize Cancer Treatment
Many immuno-oncology therapies are seeing success and showing promise for the future, including CAR-T cells, tumor-infiltrating lymphocytes (TILs), checkpoint inhibitors, and natural killer cell therapies.…
ELISA, the Most Used Immunoassay Platform in Large Molecule Bioanalysis
Biologics development is an inherently complex field. In order to carry out the stringent bioanalytical testing your studies require, you not only need expert scientists…
The Future of Bioanalytical Outsourcing: What It Means for Our Industry
Today’s pharmaceutical and biotechnology organizations must constantly innovate and evolve to meet novel requirements of developing increasingly effective (but increasingly complex) biotherapeutic innovations. This has…
Biomarkers and Immunogenicity in the Spotlight at the 2016 10th Workshop on Recent Issues in Bioanalysis
The whitepaper based on discussions at the 10th Workshop on Recent Issues in Bioanalysis (WRIB) has been published! Everyone who participated, are very excited to…